Lung Cancer Surgery Market Led by China as J&J MedTech and Medtronic Drive Innovation

According to the latest market analysis by Future Market Insights, the global lung cancer surgery market is witnessing steady growth driven by increasing early-stage lung cancer diagnosis, rising adoption of minimally invasive surgical techniques, expanding robotic-assisted thoracic surgery procedures, and growing investments in oncology infrastructure worldwide.

Market analysis indicates the lung cancer surgery market was valued at approximately USD 1.51 billion in 2025 and is projected to reach USD 1.6 billion by 2026-end before expanding significantly to USD 2.8 billion by 2036, reflecting a CAGR of 5.9% during the 2026-2036 forecast period.

The market is expected to create an incremental opportunity of approximately USD 1.2 billion between 2026 and 2036, supported by increasing lung cancer screening programs, technological advancements in thoracic surgery devices, and growing demand for precision surgical interventions.

Quick Stats: Lung Cancer Surgery Market

• Market Value (2025): USD 1.51 Billion
• Estimated Market Size (2026): USD 1.6 Billion
• Forecast Market Value (2036): USD 2.8 Billion
• CAGR (2026-2036): 5.9%
• Incremental Opportunity (2026-2036): USD 1.2 Billion
• Leading Application Segment (2026): Lobectomy - 42% Share
• Leading End User Segment (2026): Hospitals - 65% Share
• Leading Surgical Approach (2026): Minimally Invasive Surgery - 48% Share
• Leading Cancer Type Segment (2026): Non-Small Cell Lung Cancer - 80% Share
• Fastest Growing Markets: India (7.1%) and China (6.8%)

Minimally Invasive Surgery Accelerates Market Growth

Growing adoption of video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery continues to transform lung cancer treatment globally. Healthcare providers increasingly prefer minimally invasive approaches because they reduce surgical trauma, shorten hospital stays, and improve patient recovery outcomes.

Rising Lung Cancer Incidence Supports Surgical Demand

The increasing global burden of lung cancer continues to drive demand for advanced surgical treatment solutions. Earlier diagnosis through screening initiatives is expanding the pool of patients eligible for curative surgical intervention.

Growing demand is particularly evident in:

• Early-stage non-small cell lung cancer (NSCLC)
• Peripheral lung tumors
• Segmentectomy procedures
• Lobectomy procedures
• Robotic-assisted thoracic surgeries
• Lung-sparing surgical approaches

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-396

Robotic-Assisted Thoracic Surgery Creates New Growth Opportunities

Healthcare providers are increasingly investing in robotic-assisted surgical platforms to improve procedural precision and patient outcomes.

These technologies help hospitals:

• Enhance surgical visualization
• Improve instrument control
• Reduce post-operative complications
• Support complex thoracic procedures
• Increase operating room efficiency

Lobectomy Maintains Procedure Leadership

Lobectomy is expected to remain the leading application segment in 2026, accounting for approximately 42% of global market share.

Strong demand is supported by:

• Established clinical guidelines
• High success rates in operable NSCLC cases
• Wide surgeon familiarity
• Favorable long-term patient outcomes
• Growing early-stage diagnosis rates

Hospitals Lead End-User Demand

Hospitals are projected to account for approximately 65% of total market demand in 2026.

Market leadership is driven by:

• Availability of thoracic surgery specialists
• Access to intensive care infrastructure
• Multidisciplinary oncology teams
• Advanced surgical technologies
• Comprehensive post-operative care capabilities

Regional Outlook: India Leads Global Growth

India
India is projected to be the fastest-growing market globally, expanding at a CAGR of 7.1% through 2036.

Growth is supported by:

• Expansion of oncology-focused hospital networks
• Increasing adoption of robotic surgery platforms
• Improving access to cancer screening programs
• Rising healthcare infrastructure investments

China
China is expected to grow at a CAGR of 6.8% through 2036, supported by:
• Rapid expansion of tertiary care hospitals
• Growing adoption of minimally invasive thoracic surgery
• Rising lung cancer diagnosis rates
• Government-supported oncology initiatives

United States
The United States remains one of the largest markets globally and is expected to grow at a CAGR of 5.6% through 2036, supported by:
• Strong adoption of robotic-assisted surgery
• Established lung cancer screening pathways
• Advanced thoracic surgery infrastructure
• Continuous innovation in surgical technologies

United Kingdom
The UK market is projected to expand at a CAGR of 5.4% through 2036, benefiting from:

• NHS lung screening initiatives
• Earlier-stage diagnosis rates
• Increasing thoracic surgery referrals
• Expanding minimally invasive surgery programs

Customize insights for your business strategy: https://www.futuremarketinsights.com/customization-available/rep-gb-396

Competitive Landscape Focuses on Robotics, Stapling Systems, and Surgical Visualization

The lung cancer surgery market remains competitive, with leading companies focusing on robotic-assisted surgery platforms, advanced surgical staplers, and next-generation thoracic visualization technologies.

Key Industry Participants Include:

• Intuitive Surgical Inc.
• Johnson & Johnson
• Medtronic plc
• Olympus Corporation
• Karl Storz SE & Co. KG
• Richard Wolf GmbH
• FUJIFILM Holdings Corporation
• PENTAX Medical

Outlook Through 2036

The lung cancer surgery market is expected to maintain steady growth through 2036 as healthcare systems prioritize earlier diagnosis and minimally invasive treatment approaches.

Future market growth is expected to be supported by:

• Expansion of lung cancer screening programs
• Rising adoption of robotic-assisted thoracic surgery
• Increasing use of minimally invasive surgical techniques
• Technological advancements in surgical stapling systems
• Growing investments in oncology infrastructure
• Rising prevalence of non-small cell lung cancer

Explore In-Depth Healthcare Market Insights: https://www.futuremarketinsights.com/industry-analysis/healthcare

Explore Industry Insights: https://www.futuremarketinsights.com/industry-analysis

Purchase Full Report for Detailed Insights: https://www.futuremarketinsights.com/reports/lung-cancer-surgery-market

Why FMI: https://www.futuremarketinsights.com/why-fmi

Explore More Related Studies Published by FMI Research:

ePTFE Vascular Prosthesis Market: https://www.futuremarketinsights.com/reports/eptfe-vascular-prosthesis-market

Elderly Safety Monitoring Device Market: https://www.futuremarketinsights.com/reports/elderly-safety-monitoring-device-market

CRISPR Market: https://www.futuremarketinsights.com/reports/crispr-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

This release was published on openPR.